<DOC>
	<DOCNO>NCT02638831</DOCNO>
	<brief_summary>Comparative clinical study Ketorolac tromethamineand Ketoprofen gel patient Gonarthrosis Low back pain .</brief_summary>
	<brief_title>Ketorol Gel Gonarthrosis Low Back Pain</brief_title>
	<detailed_description>This Comparative evaluation therapeutic efficacy safety use drug Ketorolac tromethamine gel drug Ketoprofen gel , agent local symptomatic therapy patient diseases musculoskeletal system associate pain syndrome outpatient condition . The study include patient moderate pain syndrome gonarthrosis lower back pain ( LBP ) . The sample size 240 calculate main efficacy variable - mean pain intensity accord visual analogue scale ( VAS ) 10 day therapy . Patients subject inclusion study sign informed consent distribute study group depend establish diagnosis : Gonarthrosis group LBP group .</detailed_description>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Ketoprofen</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<criteria>General inclusion criterion : 1 . Patients sexes age group 20 70 year , sign informed consent participation study . 2 . Understanding spoken write communication , adequate able follow procedure Protocol fill document relate study . 3 . For woman : patient pregnant , breastfeed . The female patient must either postclimacteric period surgically sterile , entire period study use contraceptive method reliability level high 90 % . Methods contraception high 90 % level reliability common use include cervical cap spermicide , diaphragms spermicide , condom , oral contraceptive . Criteria inclusion group `` gonarthrosis '' : 1 . Patients sexes age group 40 70 year . 2 . Roentgenologically confirm gonarthrosis ( presence roentgenological symptom osteophytes stenosis joint space ) . 3 . Intensity pain knee joint per visual analogue scale ( VAS ) , still : ≥40 mm , movement : ≥ 50 mm . 4 . Presence one mention combination criterion : 1 . Pain knee joint last one month , accompany crepitation active movement joint , morning stiffness 30 min , age 38 year old . 2 . Pain knee joint last one month , accompany crepitation active movement joint , morning stiffness 30 min. , bone enlargement joint area . 3 . Pain knee joint last one month absence crepitation , bone enlargement joint area Criteria inclusion group `` low backpain '' : 5 . Patients sexes age group 20 65 year acute pain syndrome low part back ( less 12 week ) . 6 . Intensity pain back per VAS still ≥40 mm , movement ≥ 50 mm . 1 . Feedback Informed Consent Form sign patient participation Study . 2 . Continuation participation study conflict patient 's interest . 3 . Occurrence serious adverse event patient , relation administration drug study classify definite , probable possible . 4 . Patient need additional treatment may affect parameter efficacy study . 5 . Violations protocol , opinion investigator sponsor study , significant evaluation result clinical trial . 6 . Discontinuation study sponsor . 7 . Discontinuation study investigator . 8 . Discontinuation study regulatory body .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Pain</keyword>
	<keyword>Gonarthrosis</keyword>
	<keyword>Low Back Pain</keyword>
	<keyword>Ketorolac Tromethamine</keyword>
	<keyword>Ketoprofen</keyword>
</DOC>